Cyclosporine/Loratadine

环孢素/氯雷他定

Report date: 2026/01/21 17:00:59

Base Information

Drug NameCyclosporine/Loratadine
Drug Alias Name环孢素+氯雷他定Cyclosporine+LoratadineLoratadine/Cyclosporine氯雷他定/环孢素氯雷他定+环孢素 +[7] 
ClassificationSmall moleculesSmall molecules > Molecular Glue
Mechanisms of ActionHistamine H1 receptor antagonistsCalcineurin inhibitorsMitochondrial permeability transition pore inhibitors +[5] 
TargetsHistamine H1 receptorCalcineurinMitochondrial permeability transition pore +[4] 
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LoratadineCyclosporine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCombinatorx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCombinatorx
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A